Evaluation of thyroid disorders in pregnancy: prevalence and its varieties
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20253530Keywords:
Hypothyroidism, Pregnancy, PrevalenceAbstract
Background: Thyroid disorders represent one of the most common endocrine problems in pregnancy, with maternal hypothyroidism being the most frequent. Global prevalence of hypothyroidism during pregnancy varies widely, from 2.5% to 11%, and is reported to be higher in Asian countries compared to global estimates. The overall prevalence of thyroid disorder in pregnancy is estimated at up to 33.9% comprising hypothyroidism (31.6%) and hyperthyroidism (2.3%). Although hyperthyroidism is relatively uncommon, affecting only 0.1-0.4% of pregnancies, it is associated with greater maternal and fetal complications. Despite the higher prevalence of thyroid disorders in India, data on their distribution and adverse outcomes remain limited. Further research is therefore necessary to improve understanding and guide clinical practice in this population.
Methods: A cross-sectional study was carried out at MGM Medical College and LSK Hospital over an 18-month period. The study population included pregnant women attending the antenatal clinic. Based on the estimated prevalence of thyroid disorders in India (33.9%), the minimum required sample size was calculated as 344 participants.
Results: During the study, 344 antenatal women underwent thyroid evaluation. Of these, 112 were diagnosed with some form of thyroid disorder. The prevalence of thyroid dysfunction in pregnancy was calculated 32.56%.
Conclusions: Given this high prevalence, universal thyroid function testing at the first antenatal visit is strongly recommended. Women of higher maternal age are particularly prone to developing thyroid dysfunction. The mean TSH, FT3 and FT4 values in euthyroid participants (n=232) may serve as useful reference values for this region in future studies.
Metrics
References
Gupta P, Jain M, Verma V, Gupta NK. The study of prevalence and pattern of thyroid disorder in pregnant women: a prospective study. Cureus. 2021;13(7):e16437. DOI: https://doi.org/10.7759/cureus.16457
Unnikrishnan AG, Menon UV. Thyroid disorders in pregnancy. Indian J Endocrinol Metab. 2013;17(1):76-82.
Williams GR. Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol. 2008;20(6):784-94. DOI: https://doi.org/10.1111/j.1365-2826.2008.01733.x
Krajewski DA, Burman KD. Thyroid disorders in pregnancy. Endocrinol Metab Clin North Am. 2011;40:739-63. DOI: https://doi.org/10.1016/j.ecl.2011.08.004
Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21(10):1081-125. DOI: https://doi.org/10.1089/thy.2011.0087
Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341(8):549-55. DOI: https://doi.org/10.1056/NEJM199908193410801
Jani RS, Munshi DS, Jani SK, Munshi SP, Solanki SB, Pandya VM. Prevalence and fetomaternal outcome of thyroid disorder in pregnancy. Int J Med Sci Public Health. 2014;3(8):944-8. DOI: https://doi.org/10.5455/ijmsph.2014.260520143
Ain KB, Mori Y, Refetoff S. Reduced clearance rate of thyroxine-binding globulin (TGB) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J Clin Endocrinol Metab. 1987;65(4):689-702. DOI: https://doi.org/10.1210/jcem-65-4-689
Pratt DE, Kaberlein G, Dudkiewicz A, Karande V, Gleicher N. The association of antithyroid antibodies in euthyroid pregnant women with recurrent first trimester abortions in the next pregnancy. Fertil Steril. 1993;60(6):1001-5. DOI: https://doi.org/10.1016/S0015-0282(16)56400-0
Roushali K, Bansal R, Kaur H Shergill, Garg P. Prevalence of thyroid dysfunction in pregnancy and its association with feto-maternal outcomes: A prospective observational study from a tertiary care institute in Northern India. Clin Epidemiol Glob Health. 2023;19:101201. DOI: https://doi.org/10.1016/j.cegh.2022.101201
Dasgupta A, Dasgupta S, Sarkar S, Mandal A. Pattern of thyroid disorders in pregnancy in a tertiary care hospital in eastern India. J Fam Med Prim Care. 2017;6(2):261-5.
Yassaee F, Farahani M, Abadi AR. Prevalence of subclinical hypothyroidism in pregnant women in Tehran, Iran. Int J Fertil Steril. 2014;8(2):163-6.
Dhanwal DK, Prasad S, Agarwal AK, Dixit V, Banerjee AK. High prevalence of subclinical hypothyroidism during first trimester of pregnancy in North India. Indian J Endocrinol Metab. 2013;17(2):281-4. DOI: https://doi.org/10.4103/2230-8210.109712
Gayathri R, Lavanya S, Raghavan K. Subclinical hypothyroidism and autoimmune thyroid disease in pregnancy. Indian J Endocrinol Metab. 2012;16(4):552-4.
Ramprasad M, Bhattacharyya A, Bhattacharyya A, et al. Prevalence of thyroid disorders in pregnant women from eastern India: A single-centre study. Indian J Endocrinol Metab. 2018;22(3):410-3.
Gopinath P, Valappil VE, Gomathi KG, Thomas N, Rajaratnam S. Prevalence of hypothyroidism in pregnancy: An epidemiological study from 11 cities in 9 states of India. Indian J Endocrinol Metab. 2016;20(3):387-90. DOI: https://doi.org/10.4103/2230-8210.179992
Mithal A, Bansal B, Kalra S. Gestational diabetes in India: Science and society. Indian journal of endocrinology and metabolism. 2015;19(6):701-4. DOI: https://doi.org/10.4103/2230-8210.164031
Downloads
Published
How to Cite
Issue
Section
